医学
痴呆
混淆
置信区间
内科学
队列研究
队列
倾向得分匹配
随机对照试验
观察研究
临床试验
物理疗法
疾病
作者
Erin Bennett,Chelsea Liu,Emma K. Stapp,Kan Z. Gianattasio,Scott C. Zimmerman,Jingkai Wei,Michael Griswold,Annette L. Fitzpatrick,Rebecca F. Gottesman,Lenore J. Launer,B. Gwen Windham,Deborah A. Levine,Alison E. Fohner,M. Maria Glymour,Melinda C. Power
出处
期刊:Epidemiology
[Lippincott Williams & Wilkins]
日期:2024-10-01
标识
DOI:10.1097/ede.0000000000001802
摘要
Background: Observational studies link high midlife systolic blood pressure to increased dementia risk. However, synthesis of evidence from randomized controlled trials has not definitively demonstrated that antihypertensive medication use reduces dementia risk. Here, we emulate target trials of antihypertensive medication initiation on incident dementia using three cohort studies, with attention to potential violations of necessary assumptions. Methods: We emulated trials of antihypertensive medication initiation on incident dementia using data from the Atherosclerosis Risk in Communities (ARIC) study, Cardiovascular Health Study (CHS), and Health and Retirement Study (HRS). We used data-driven methods to restrict participants to initiators and non-initiators with overlap in propensity scores and positive control outcomes to look for violations of positivity and exchangeability assumptions. Results: Analyses were limited by the small number of cohort participants who met eligibility criteria. Associations between antihypertensive medication initiation and incident dementia were inconsistent and imprecise (ARIC: HR = 0.30 [0.05, 1.93]; CHS: HR = 0.66 [0.27, 1.64]; HRS: HR = 1.09 [0.75, 1.59]). More stringent propensity score restriction had little effect on findings. Sensitivity analyses using a positive control outcome unexpectedly suggested antihypertensive medication initiation increased risk of coronary heart disease in all three samples. Conclusions: Positive control outcome analyses suggested substantial residual confounding in effect estimates from our target trials, precluding conclusions about the impact of antihypertensive medication initiation on dementia risk through target trial emulation. Formalized processes for identifying violations of necessary assumptions will strengthen confidence in target trial emulation and avoid inappropriate confidence in emulated trial results.
科研通智能强力驱动
Strongly Powered by AbleSci AI